C22 -Malignant neoplasm of liver and intrahepatic bile ducts

Specify the patient
Clinical stage TNM
Analysis settings
Analysis settings Change diagnosis
Export options
Applied filters (reset filters)
Sex:  | Age:  | Region:  | Period: 

C22 – N =16,992

Year Stage 1 Stage 2 Stage 3 Stage 4 Not recorded Total sum
1995 0.8% 3.5% 8.5% 27% 60.2% 797
1996 1.8% 2.4% 6.2% 23.7% 65.9% 820
1997 1.4% 3.8% 5.3% 24.6% 64.9% 848
1998 1.7% 3.3% 7.1% 24.1% 63.8% 820
1999 1.7% 3.7% 7.7% 25.2% 61.7% 806
2000 0.5% 2.2% 6% 23% 68.3% 783
2001 1% 2.6% 7.1% 29.8% 59.4% 764
2002 1.2% 2% 5% 31.9% 59.9% 805
2003 1.8% 2.6% 7.3% 32.4% 55.8% 831
2004 1.9% 2.4% 8.6% 28.4% 58.6% 777
2005 3.9% 3.8% 10.9% 23.2% 58.2% 874
2006 3.2% 4.1% 13.1% 28.7% 50.9% 850
2007 3.8% 4.5% 15.5% 33.4% 42.8% 925
2008 4.5% 6.8% 20.4% 39.7% 28.7% 869
2009 3.3% 7.4% 23.5% 38.7% 27.2% 843
2010 5% 7.5% 22.9% 41.8% 22.7% 981
2011 4.3% 8% 10.9% 42.2% 34.6% 928
2012 5.9% 10.7% 11.6% 36.2% 35.6% 862
2013 4% 8.2% 11.7% 37.9% 38.2% 903
2014 5.2% 8.3% 14% 37.3% 35.2% 906

C22 -Malignant neoplasm of liver and intrahepatic bile ducts

Specify the patient
Clinical stage TNM
Analysis settings
Change diagnosis
Export options
Applied filters (reset filters)
Sex:  | Age:  | Region:  | Period: 

C22 – N =16,992

Year Stage 1 Stage 2 Stage 3 Stage 4 Not recorded Total sum
1995 6 28 68 215 480 797
1996 15 20 51 194 540 820
1997 12 32 45 209 550 848
1998 14 27 58 198 523 820
1999 14 30 62 203 497 806
2000 4 17 47 180 535 783
2001 8 20 54 228 454 764
2002 10 16 40 257 482 805
2003 15 22 61 269 464 831
2004 15 19 67 221 455 777
2005 34 33 95 203 509 874
2006 27 35 111 244 433 850
2007 35 42 143 309 396 925
2008 39 59 177 345 249 869
2009 28 62 198 326 229 843
2010 49 74 225 410 223 981
2011 40 74 101 392 321 928
2012 51 92 100 312 307 862
2013 36 74 106 342 345 903
2014 47 75 127 338 319 906

C22 -Malignant neoplasm of liver and intrahepatic bile ducts

Specify the patient
Age Clinical stage TNM
Analysis settings
Analysis settings Change diagnosis
Export options
Applied filters (reset filters)
Sex:  | Region:  | Period:  

C22 – N =16,992

Age category Stage 1 Stage 2 Stage 3 Stage 4 Not recorded Total sum
0–19 4.5% 4.5% 22.7% 16.7% 51.5% 66
20–24 0% 0% 23.1% 38.5% 38.5% 13
25–29 2.7% 5.4% 18.9% 35.1% 37.8% 37
30–34 5% 7.5% 15% 50% 22.5% 40
35–39 5.5% 4.1% 5.5% 38.4% 46.6% 73
40–44 2.6% 5.7% 12% 31.3% 48.4% 192
45–49 2% 4.7% 9% 33.3% 50.9% 444
50–54 2.9% 5.4% 8.8% 34.3% 48.6% 986
55–59 2.8% 4.9% 12.5% 35.3% 44.5% 1,650
60–64 3.7% 6% 13% 32.9% 44.3% 2,316
65–69 2.5% 5% 12.4% 34.8% 45.2% 2,710
70–74 3.4% 5.4% 11.3% 30.4% 49.4% 2,967
75–79 3.3% 5.3% 10.8% 30.2% 50.4% 2,526
80–84 2.1% 3.4% 10.4% 28.2% 55.9% 1,820
85+ 1.9% 3.6% 9.5% 26.3% 58.7% 1,152

C22 -Malignant neoplasm of liver and intrahepatic bile ducts

Specify the patient
Age Clinical stage TNM
Analysis settings
Change diagnosis
Export options
Applied filters (reset filters)
Sex:  | Region:  | Period:  

C22 – N =16,992

Age category Stage 1 Stage 2 Stage 3 Stage 4 Not recorded Total sum
0–19 3 3 15 11 34 66
20–24 0 0 3 5 5 13
25–29 1 2 7 13 14 37
30–34 2 3 6 20 9 40
35–39 4 3 4 28 34 73
40–44 5 11 23 60 93 192
45–49 9 21 40 148 226 444
50–54 29 53 87 338 479 986
55–59 46 81 207 582 734 1,650
60–64 86 140 302 763 1,025 2,316
65–69 69 136 336 944 1,225 2,710
70–74 102 161 334 903 1,467 2,967
75–79 83 133 273 764 1,273 2,526
80–84 38 62 190 513 1,017 1,820
85+ 22 42 109 303 676 1,152